Charles MA - Search Results

1

Risk factors for NIDDM in white population. Paris prospective study.

Charles MA, Fontbonne A, Thibult N, Warnet JM, Rosselin GE, Eschwege E. Charles MA, et al. Diabetes. 1991 Jul;40(7):796-9. doi: 10.2337/diab.40.7.796. Diabetes. 1991. PMID: 2060716

2

The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study.

Charles MA, Eschwège E, Thibult N, Claude JR, Warnet JM, Rosselin GE, Girard J, Balkau B. Charles MA, et al. Diabetologia. 1997 Sep;40(9):1101-6. doi: 10.1007/s001250050793. Diabetologia. 1997. PMID: 9300248

3

[Non-insulin-dependent diabetes in populations at risk: the Pima Indians].

Charles MA, Eschwège E, Bennett PH. Charles MA, et al. Diabetes Metab. 1997 Nov;23 Suppl 4:6-9. Diabetes Metab. 1997. PMID: 9463026 Review. French.

4

High plasma nonesterified fatty acids are predictive of cancer mortality but not of coronary heart disease mortality: results from the Paris Prospective Study.

Charles MA, Fontbonne A, Thibult N, Claude JR, Warnet JM, Rosselin G, Ducimetière P, Eschwège E. Charles MA, et al. Am J Epidemiol. 2001 Feb 1;153(3):292-8. doi: 10.1093/aje/153.3.292. Am J Epidemiol. 2001. PMID: 11157417

5

Reproducibility of the diagnosis of diabetes over a 30-month follow-up: the Paris Prospective Study.

Eschwège E, Charles MA, Simon D, Thibult N, Balkau B; Paris Prospective Study. Eschwège E, et al. Among authors: charles ma. Diabetes Care. 2001 Nov;24(11):1941-4. doi: 10.2337/diacare.24.11.1941. Diabetes Care. 2001. PMID: 11679461

6

From policemen to policies: what is the future for 2-h glucose? The Kelly West Lecture, 2000.

Eschwège E, Charles MA, Simon D, Thibult N, Balkau B. Eschwège E, et al. Among authors: charles ma. Diabetes Care. 2001 Nov;24(11):1945-50. doi: 10.2337/diacare.24.11.1945. Diabetes Care. 2001. PMID: 11679462

7

Hepatic markers and development of type 2 diabetes in middle aged men and women: a three-year follow-up study. The D.E.S.I.R. Study (Data from an Epidemiological Study on the Insulin Resistance syndrome).

André P, Balkau B, Born C, Royer B, Wilpart E, Charles MA, Eschwège E. André P, et al. Among authors: charles ma. Diabetes Metab. 2005 Dec;31(6):542-50. doi: 10.1016/s1262-3636(07)70229-x. Diabetes Metab. 2005. PMID: 16357802

8

Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up.

Fontbonne A, Charles MA, Thibult N, Richard JL, Claude JR, Warnet JM, Rosselin GE, Eschwège E. Fontbonne A, et al. Among authors: charles ma. Diabetologia. 1991 May;34(5):356-61. doi: 10.1007/BF00405009. Diabetologia. 1991. PMID: 1864491

9

The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution. BIGPRO Study Group.

Fontbonne A, Charles MA, Juhan-Vague I, Bard JM, André P, Isnard F, Cohen JM, Grandmottet P, Vague P, Safar ME, Eschwège E. Fontbonne A, et al. Among authors: charles ma. Diabetes Care. 1996 Sep;19(9):920-6. doi: 10.2337/diacare.19.9.920. Diabetes Care. 1996. PMID: 8875083 Clinical Trial.

10

[Revision of diagnostic criteria of diabetes. The reasons and the consequences].

Charles MA, Simon D, Balkau B, Eschwege E. Charles MA, et al. Diabetes Metab. 1998 Feb;24(1):75-9. Diabetes Metab. 1998. PMID: 9534014 Review. French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

569 results

Search Page

Filters